VRT752271 (BVD-523, Ulixertinib) is an orally available, highly selective, ATP-competitive, reversible ERK1/2 inhibitor with an IC50 of <0.3 nM for ERK2 inhibition.
Molecular Weight:
433.33
Purity:
100.00%
CAS Number:
[869886-67-9]
Formula:
C21H22Cl2N4O2
Target:
ERK
* VAT and and shipping costs not included. Errors and price changes excepted